Search for: "Quark, Inc." Results 1 - 20 of 20
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Jun 2007, 3:29 am
Inc. magazine is asking for your feedback and vote on your favorite of four startups recently profiled by the Magazine. [read post]
15 Jul 2008, 4:57 am
The patent was opposed by several companies involved in commercializing RNA interference (RNAi), including Sanofi-Aventis Deutschland GmbH, Sirna Therapeutics, Nucleonics, Inc., Quark Biotech, and Silence Therapeutics AG. [read post]
10 Dec 2008, 9:09 am
Quark Inc. announced today that it has available a manual, online content and a free video to help creative professionals to make the most of its design tools. [read post]
19 May 2011, 6:21 pm by Tomassi Law Associates
Scientists at the WM Keck Center for Collaborative Neuroscience and Quark Pharmaceuticals Inc. have developed a chemically synthesized siRNA molecule that decreases the production of the RhoA protein when administered to the spine and allows regeneration of the nerve cells. [read post]
13 Aug 2008, 3:43 am
Other new members include Synopsis, Inc., SAP, Quest Software, Inc., Parametric Technology Corporation (PTC), Monotype Imaging, and Quark Inc., producers of QuarkXpress ®. [read post]
13 Aug 2008, 3:43 am
Other new members include Synopsis, Inc., SAP, Quest Software, Inc., Parametric Technology Corporation (PTC), Monotype Imaging, and Quark Inc., producers of QuarkXpress ®. [read post]
14 Aug 2010, 12:46 am by Robert Thomas (inversecondemnation.com)
My Damon Key colleagues Mark Murakami and Tred Eyerly and I have posted our forthcoming essay Of Woodchucks and Prune Yards: A View of Judicial Takings From the Trenches on SSRN here, containing our thoughts on Stop the Beach Renourishment, Inc. v. [read post]
30 Aug 2012, 12:32 pm
Keck Center for Collaborative Neuroscience, in collaboration with Quark Pharmaceuticals, Inc., have developed a chemically synthesized siRNA molecule that once administered to the injured spine decreases the production of the RhoA protein, therefore allowing the regeneration of the nerve cells. [read post]
30 Aug 2012, 12:32 pm
Keck Center for Collaborative Neuroscience, in collaboration with Quark Pharmaceuticals, Inc., have developed a chemically synthesized siRNA molecule that once administered to the injured spine decreases the production of the RhoA protein, therefore allowing the regeneration of the nerve cells. [read post]
9 Jul 2012, 1:00 pm
Keck Center for Collaborative Neuroscience, in collaboration with Quark Pharmaceuticals, Inc., have developed a chemically synthesized siRNA molecule that once administered to the injured spine decreases the production of the RhoA protein, therefore allowing the regeneration of the nerve cells. [read post]
26 Feb 2012, 1:17 pm by Hedge Fund Lawyer
. **** April 18, 2012 4:30 – 6:00 Joint NIBA/CTAEXPO Cocktail Party, Sponsored by Telvent DTN April 19, 2012 8:30 – 9:30 Continental Breakfast Sponsored by DMAXX 9:15 – 9:30 Welcoming Remarks Bucky Isaacson and Frank Pusateri 9:30 – 10:00 An Insider’s View of Marketing Elaine Llyod | Axion Services Group Sponsored by BNY Mellon 10:00 – 10:30 How Family Offices Select Managers Audie Apple | Bessemer Trust Sponsored by Horizon Cash Management 10:30 – 11:00… [read post]
10 Mar 2015, 5:54 pm by Ryan E. Long
According to Turning Profit from Music Mashups, New York based tech company Dubset Media, Inc., collects royalties from mash up artists who use other copyrighted songs in their works. [read post]
10 Mar 2015, 5:54 pm by Ryan E. Long
According to Turning Profit from Music Mashups, New York based tech company Dubset Media, Inc., collects royalties from mash up artists who use other copyrighted songs in their works. [read post]
16 Jul 2012, 10:51 am
Keck Center, en colaboración con Quark Pharmaceuticals, Inc., han sintetizado químicamente una molécula siRNA que una vez administrada a la columna lesionada disminuye la producción de la proteína de RhoA, permitiendo la regeneración de las células nerviosas. [read post]
30 Aug 2012, 1:19 pm
Keck Centro para la Neurociencia Colaborativa, en colaboración con Quark Pharmaceuticals, Inc., han desarrollado una molécula química siRNA que una vez administrada a la columna lesionada disminuye la producción de la proteína de RhoA y por lo tanto, permite la regeneración de las células de los nervios dañados. [read post]
16 Jul 2012, 10:51 am
Keck Center, en colaboración con Quark Pharmaceuticals, Inc., han sintetizado químicamente una molécula siRNA que una vez administrada a la columna lesionada disminuye la producción de la proteína de RhoA, permitiendo la regeneración de las células nerviosas. [read post]
9 Mar 2021, 11:56 am by admin
Modern physics addresses whether we must be content with probability statements, rather than precise deterministic “billiard ball” physics, which is so useful in a game of snooker, but less so in describing quarks. [read post]